The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. (Q39836423)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. |
scientific article |
Statements
1 reference
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. (English)
1 reference
Heinz-Josef Lenz
1 reference
Melissa J LaBonte
1 reference
Philipp C Manegold
1 reference
Peter M Wilson
1 reference
Will Fazzone
1 reference
Stan G Louie
1 reference
Robert D Ladner
1 reference
1 December 2009
1 reference
1 reference
125
1 reference
12
1 reference
2957-2969
1 reference
Identifiers
1 reference
1 reference